Text Size

Use of a Cationic Emulsion of Latanoprost to Treat Glaucoma Patients with Ocular Surface Disease: A Preclinical Review

Daull P., Garrigue J.-S., Liang H., Baudouin C.

  • 2023
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area


  • Categories

    Preclinical development

  • Affiliations

    Santen SAS, Evry, France; Department of Ophthalmology, Quinze-Vingts Hospital, Paris, France

Related Publications

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation

Pereira ICF, van Mechelen RJS, Wyss HM, Pinchuk L, Beckers HJM, den Toonder JMJ.

Latanoprost incorporates in the tear film lipid layer: An experimental and computational model study

Riedlová K, Saija MC, Olżyńska A, Vazdar K, Daull P, Garrigue JS, Cwiklik L.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022